chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Sep2021 as dose 3 (booster), single (Lot number: FC3184) at the age of 66 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing), notes: verbatim: Known allergies: Sulfa. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: Positive, notes: After testing positive for Covid-19 on Day 1; Negative, notes: Negative antigen test on Day 11; Negative, notes: Negative antigen test Day 13; Positive, notes: Positive antigen test Day 14 - Covid-19 relapse on Day 14 post-Paxlovid treatment. Therapeutic measures were taken as a result of covid-19.  Clinical course: After testing positive for Covid-19 on Day 1, took Paxlovid on Day 2 through Day 7. Symptoms abated except for fatigue. Negative antigen test on Day 11. Symptoms started to return Day 12. Negative antigen test Day 13. Symptoms continued to get worse. Positive antigen text Day 14 - Covid-19 relapse on Day 14 post-Paxlovid treatment.
Hypotension and dizzyness, normally 120/85, 107/77 while exercising. Became nauseated also.
the vaccine dripped out in my arm and it was on my hand. Then they give me a very small dose about a quarter of a dose in my other arm; the vaccine dripped out in my arm and it was on my hand. Then they give me a very small dose about a quarter of a dose in my other arm; A spontaneous report  received from a health care professional concerning, 39-year-old age female patient who received second dose of the Moderna COVID-19 vaccine and vaccine dripped out in my arm and it was on my hand. Then they give me a very small dose about a quarter of dose in my other are.    The patient's medical history was not included. Patient's concomitant was not included.  On 22 Jan 2021 date, the patient received their second dose of the two planned doses of mRNA-1273 in unknown arm (Batch #: 012L20A) intramuscularly for prophylaxis of COVID-19 infection.   Patient stated that she was vaccinated with her second dose of the Moderna COVID-19 vaccine on 22 Jan 2021. Patient stated that the vaccine dripped out of her arm and it was on her hand. Patient stated they then gave her a very small dose about a quarter of a dose in her other arm. Patient wants to know if the dose was enough.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   The outcome of the event was considered as recovered.; Reporter's Comments: This report refers to a case of 39-year-old female who experienced nonserious unexpected events of Exposure via skin contact and Incomplete dose administered for mRNA-1273, lot # 012L20A with no associated adverse events.
Felt pain in both of his hands, in his entire hand, after the first vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 57 year-old male patient received bnt162b2 (BNT162B2), administration date 22Apr2021 (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (ongoing), notes: Consumer also added that her father regularly takes medications for his blood pressure, nose, and ear. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Felt pain in both of his hands, in his entire hand, after the first vaccine".  Additional information included as she and her 57-year-old father received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine on 22APR2021 and are both scheduled to receive the 2nd dose on 17MAY2021. On the 4th or 5th day after the 1st dose, her father felt pain on both of his hands. Then after 2 days, he felt okay again. She wants to know if this is a common reaction to the vaccine, and how bad would the side effects be after the 2nd dose. She also wants to know the common side effects after the 2nd dose. Consumer also added that her father regularly takes medications for his blood pressure, nose, and ear. She said he did not stop even before and after his 1st dose of the Pfizer-BioNTech Covid-19 Vaccine. Caller stated that her father had the first dose of vaccine, and after 5 days, reclarified, he felt pain in both of his hands, in his entire hand. Caller states he did not feel this immediately after the vaccine. Caller states her family all took the vaccine together, and some of her family had slight weakness. Caller stated that her father never had that pain before.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Achy). At the time of the report, PAIN (Achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
fatigue, achy, headache, malaise Narrative:  on day 2 patient reported, fatigue, body aches, headache and malaise. Took OTC Tylenol and Nurtec prescription.
She got her vaccine, about an hour afterwards she got a headache that she suspected.  Later that night was vomiting, and would be fine, and then it kept going every day until present.  She is  now going to a GI doctor to see what is going on.  They have ruled out reflux, her gallbladder, and the only common denominator is the vaccine.  She was put on Protonix, Cimetidine, Phenergan for the nausea and vomiting, which have not improved her symptoms.  The Phenergan helps some but she cannot take it all the time as she is working and in school and cannot be sedated.     The vomiting would start after she ate dinner, and it has now progressed where she vomits more often and is not helping, and as said have already ruled out reflux.    The only thing that they have found that she has something wrong with her portal vein and her common bile duct is slightly dilated but not blocked.
For the first event, within this time was when I was at work, I started to get a bad headache towards the end of the day and that's when they posted an email for any allergy or symptoms with congestion or headaches, they suggested to go to the employee health clinic. I told them I had headache, congestion, and low-grade fever. So they set up time for me to go get tested before I left work and made sure that I wasn't supposed to go in the next day until we got the results back. Then the next day, I got results back and I was negative, and I was able to go back into work if I wasn't having a fever. Then right after that, about a week later. I ended up having more symptoms on January 13, 2022. I woke up that morning with headache, congestions, very fatigued. The PA at the clinic recommended me to get tested. Tested me for COVID and Flu A & B and RSV, if I came back negative, she wanted me to get tested again with a respiratory panel. 01/14/2022, I went back in for another respiratory panel to make sure I tested negative again which I did that day. With those 2 days, it was just a lot of congestion, a really bad headache and just a low grade fever (99.8). No treatment.
Information has been received from a licensed practical nurse concerning a 9 year old male with an ibuprofen allergy who on 09/21/2001 was vaccinated with a first dose of vaicella SC. The pt developed a sore throat, fever and mild blister-like rash on belly and back on 09/24/2001. He was seen by the doctor on 09/24/2001 and was diagnosed with chicken pox. The pt had about 20 lesions. The pt seemed to be getting better, but on 10/08/2001, the pt's mother reported that the pt had many more lesions. It was reported that the pt recovered. The nurse reported that the pt's sister also developed varicella after vaccination with varicella vaccine. No additional info is expected.
Patient reports he received both flu and COVID booster in left upper arm and developed severe left upper arm pain and loss of range of motion that persistent over 1 month.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and sex who on an unknown date, were vaccinated with improperly stored doses of GARDASIL lot # K007264, expiration date 02-MAR-2017, through an unspecified route. No adverse effects were reported. The outcome of incorrect product storage was unknown. This is one of several reports received from the same source. Additional information has been requested.
Onset of right temple pain and right eye water approximately 3 hours after 2nd dose moderna vaccine. Progressed to right facial paralysis, increased eye watering, unable to completely close right eye or raise right side of face, drooling with drinking liquids. Called primary care physician 4/1/2021, referred to ED.  Evaluated by  ER provider, FNP on 4/1/2021,  exam findings consistent with Bell's Palsy  with no other neurological deficits noted. Nursing staff assisted pt with completing report, pt listed as reporter for follow-up.
Shingles 5 years after being fully vaccinated/ Suspected vaccination failure; Shingles; rash between legs and face, rash on their head; hair falling out; a rash on their head that is very itchy; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, 5 years after receiving Shingrix and unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash, hair loss and itchy rash. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, rash, hair loss and itchy rash were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, rash, hair loss and itchy rash to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 20-OCT-2022 Reporter's Comments: The reporter was the patient.  The patient reported experiencing diagnosed Shingles approximately 5 years after being fully vaccinated with Shingrix.  The reporter reported having a rash between their legs and on his face, which did not itch.  The patient reported diagnosed Shingles resolved.  The patient reported he believed he was experiencing a second case of Shingles since being vaccinated, was not yet been diagnosed.  The patient reported having a rash on their head that was very itchy, their hair was falling out when they comb it.  The reporter did not consent to follow up. Additional information: This case was considered as suspected vaccination failure as detail regarding laboratory confirmation was unknown at the time of reporting.
Sore arm leading to all over body soreness. Red injection site that later became a rash.
Tingling in lips and left side of face felt numb 20 minutes after vaccine.  No treatment, resolved in 3 hours.
Imm administered 12-15-08.  12-19-08 presented to ACHD.  c/o itching rash at site of both PEDIARIX and PREVNAR last pm.  12-19 no itching present.  No treatment.
No additional AE details are available; patient received a dose of MMR II on 5/11/2021 that had expired on 5/9/2021; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of unknown gender. No information regarding the patient's concomitant medications, medical history, drug reactions or allergies was provided.  On 11-MAY-2021, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA), 0.5 mL, lot # S014431, expiration date 09-MAY-2021 (route of administration was not provided) for prophylaxis. The reporter denied the product had had any temperature excursions. No adverse event was reported.
mistakenly, received her second dose of the Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (mistakenly, received her second dose of the Moderna Covid-19 vaccine) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 06-May-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 03-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (mistakenly, received her second dose of the Moderna Covid-19 vaccine). On 03-Jun-2021, INTERCHANGE OF VACCINE PRODUCTS (mistakenly, received her second dose of the Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported.
This spontaneous report was received from an office manager and refers to a 12 month-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 11-NOV-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.
Patient presented a prescription from her Dr. for bactroban ointment and said Dr. told her she had a staff infection. The infection was in the same area as vaccine was given.
C/O clear runny nose x1 day. C/O fever 103-104. Fussy, positive influenza (A) positive.
Patient did not experience any adverse event, but was given a booster dose 2 months earlier than should have been given
Reported to school nurse that she developed headache, nausea, and throat "felt funny."  No medical evaluation.  Returned to school on 12/8/09.
Patient called 6/2/21 and stated that he had a blood clot on his leg and was asking if it was because of the covid vaccine that he had received on 5/18/21.  Patient had self-diagnosed and at time of call, had not sought medical attention.  Described as a huge, red spot on his thigh that was about the size of his hand.  Located on right thigh, on top, almost by inner thigh.  Stated appearance was red/rose colored, and was getting darker like a sunburn.  Approximately 10 inches long and 4 inches wide.  Hurts when he stands up, and rated a 5/10 for pain level.    Vaccine administered 5/18/21 and symptoms appeared 5/29/21.  Advised patient to seek medical care.    Patient asked for contact numbers and provided Pfizer and CDC .  Patient called Pfizer and representative stated that a report would be made.    Noted that patient was prescribed anastrozole and this may cause venous thromboembolism in about 3% of patients.  Patient was informed of this during a follow up call and advised to call prescriber, and again to seek medical attention.  Prescriber was notified 6/2/21 in regards to the symptoms reported, and advised regarding possible adverse drug event.
ITCHING; INVOLUNTARY BODY MOVEMENTS; INVOLUNTARY SPEAKING; STOMACH PAIN; LOSS OF APPETITE; BODY ACHES; LOSS OF TASTE; OVERALL SENSITIVE SKIN-TO TOUCH; EAR PAIN; TEETH CLENCHING; GENERAL FEELING OF MALAISE; RASH; HIGH FEVER; HEADACHE; EXTREME FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On MAR-2021, the subject experienced itching. On MAR-2021, the subject experienced involuntary body movements. On MAR-2021, the subject experienced involuntary speaking. On MAR-2021, the subject experienced stomach pain. On MAR-2021, the subject experienced loss of appetite. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced loss of taste. On MAR-2021, the subject experienced overall sensitive skin-to touch. On MAR-2021, the subject experienced ear pain. On MAR-2021, the subject experienced teeth clenching. On MAR-2021, the subject experienced general feeling of malaise. On MAR-2021, the subject experienced rash. On MAR-2021, the subject experienced high fever. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced extreme fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from loss of appetite, extreme fatigue, and general feeling of malaise, and the outcome of rash, itching, high fever, involuntary body movements, involuntary speaking, stomach pain, headache, body aches, loss of taste, overall sensitive skin-to touch, ear pain and teeth clenching was not reported. This report was non-serious.
I have Dupuytren's Disease that was diagnosed 11/30/2021 by my doctor.  This is an autoimmune disease that I believe was dormant and may have been activated by the COVID vaccinations I had.  As a result of Dupuytren's, I now have lymphedema in my right arm even though I had not developed it since my cancer treatment (radical mastectomy, chemo and radiation) beginning 4/3/2001 (21 years ago).  I had to retire from my career of 48 years in court reporting and captioning because of the Dupuytren's Disease and low back pain that caused me to have back surgery 8/5/2021.
Information has been received from a female consumer who was vaccinated with a dose of ZOSTAVAX on an unspecified date.  Subsequently, the patient experienced a hot, red bump at the injection site.  No medical attention was sought.  The outcome of this event was unspecified.  No product quality complaint was involved.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 12/21/2007. Information has been received from a 60-year-old female consumer with hypertension, GERD and sulfa allergy who was vaccianted with a dose of ZOSTAVAX (Oka/Merck) on 18-OCT-2007. At the time of vaccination the patient had an imparied fasting glucose. Subsequently, "two days after vaccination" on 20-OCT-2007, the patient experienced a local injeciton site reaction characterized by redness, swelling, heat, and red bump at the injection site. No medical attention was sought at the office as it was reported that the patient was on vacation; therefore, no laboratory or diagnostic tests were performed. The outcome of this events was reported as recovered as of 28-OCT-2007. No product quality complaint was involved. Additional information is not expected.
RESTLESSNESS; DIZZINESS; SORENESS IN ARM; SORENESS IN LEGS; WEAKNESS; COLD; CHILLS; FEVER; This spontaneous report received from a patient concerned a 32 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included overweight, and dull pain.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination at left arm. No concomitant medications were reported. On 21-MAR-2021, the subject experienced restlessness. On 21-MAR-2021, the subject experienced dizziness. On 21-MAR-2021, the subject experienced soreness in arm. On 21-MAR-2021, the subject experienced soreness in legs. On 21-MAR-2021, the subject experienced weakness. On 21-MAR-2021, the subject experienced cold. On 21-MAR-2021, the subject experienced chills. On 21-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness in arm, soreness in legs, restlessness, dizziness, weakness, cold, chills, and fever. This report was non-serious.
Spells of intense vertigo while lying down or turning head from side to side. It started when rolling over in bed, two days after the vaccination, and persisted severely for four days. Slowly the sensation faded over a ten-day period.
mom described pain, redness & hard red knot on lt arm-t101 treated w/cold compresses & APAP;no further medical treatment needed;
Client stated she noticed red bumps to skin and itching (Generalized) ten days after vaccine was administered.
COVID arm; red blister - left elbow; pain in the left elbow - really painful; elbow was beet red - left elbow; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE VESICLES (red blister - left elbow), VACCINATION SITE PAIN (pain in the left elbow - really painful) and VACCINATION SITE ERYTHEMA (elbow was beet red - left elbow) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE VESICLES (red blister - left elbow), VACCINATION SITE PAIN (pain in the left elbow - really painful) and VACCINATION SITE ERYTHEMA (elbow was beet red - left elbow). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency and ANTIBIOTICS at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE VESICLES (red blister - left elbow), VACCINATION SITE PAIN (pain in the left elbow - really painful) and VACCINATION SITE ERYTHEMA (elbow was beet red - left elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided
Difficulty swallowing. Sensation of lip swelling. Immediate Care response activated. IV Benadryl, Solumedrol and Pepcid given. Patient taken to   Care Center for observation and further care.